AU4372096A - Sustained-release drug delivery employing a powdered hydrocolloid gum obtainable from higher plants - Google Patents

Sustained-release drug delivery employing a powdered hydrocolloid gum obtainable from higher plants

Info

Publication number
AU4372096A
AU4372096A AU43720/96A AU4372096A AU4372096A AU 4372096 A AU4372096 A AU 4372096A AU 43720/96 A AU43720/96 A AU 43720/96A AU 4372096 A AU4372096 A AU 4372096A AU 4372096 A AU4372096 A AU 4372096A
Authority
AU
Australia
Prior art keywords
sustained
drug delivery
release drug
higher plants
hydrocolloid gum
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU43720/96A
Other versions
AU709413B2 (en
Inventor
Syed A Altaf
David R Friend
Eric H. Kuhrts
Jagdish Parasrampuria
Karen Yu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Amarin Development AB
Original Assignee
Cibus Pharmaceutical Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cibus Pharmaceutical Inc filed Critical Cibus Pharmaceutical Inc
Publication of AU4372096A publication Critical patent/AU4372096A/en
Application granted granted Critical
Publication of AU709413B2 publication Critical patent/AU709413B2/en
Assigned to VENTURE LENDING reassignment VENTURE LENDING Alteration of Name(s) in Register under S187 Assignors: CIBUS PHARMACEUTICAL, INC.
Assigned to AMARIN DEVELOPMENT AB reassignment AMARIN DEVELOPMENT AB Alteration of Name(s) in Register under S187 Assignors: VENTURE LENDING
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4808—Preparations in capsules, e.g. of gelatin, of chocolate characterised by the form of the capsule or the structure of the filling; Capsules containing small tablets; Capsules with outer layer for immediate drug release

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
AU43720/96A 1994-12-01 1995-11-30 Sustained-release drug delivery employing a powdered hydrocolloid gum obtainable from higher plants Ceased AU709413B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US34851594A 1994-12-01 1994-12-01
US08/348515 1994-12-01
PCT/US1995/015593 WO1996016638A1 (en) 1994-12-01 1995-11-30 Sustained-release drug delivery employing a powdered hydrocolloid gum obtainable from higher plants

Publications (2)

Publication Number Publication Date
AU4372096A true AU4372096A (en) 1996-06-19
AU709413B2 AU709413B2 (en) 1999-08-26

Family

ID=23368363

Family Applications (1)

Application Number Title Priority Date Filing Date
AU43720/96A Ceased AU709413B2 (en) 1994-12-01 1995-11-30 Sustained-release drug delivery employing a powdered hydrocolloid gum obtainable from higher plants

Country Status (9)

Country Link
EP (1) EP0793485A4 (en)
JP (1) JPH10509981A (en)
CN (1) CN1172429A (en)
AU (1) AU709413B2 (en)
CA (1) CA2205351A1 (en)
FI (1) FI972304A (en)
MX (1) MX9704043A (en)
NO (1) NO972486L (en)
WO (1) WO1996016638A1 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5811388A (en) * 1995-06-07 1998-09-22 Cibus Pharmaceutical, Inc. Delivery of drugs to the lower GI tract
IL119627A (en) * 1996-11-17 2002-03-10 Yissum Res Dev Co PHARMACEUTICAL PREPARATIONS FOR THE CONTROLLED-RELEASE OF AN ACTIVE AGENT COMPRISING AT LEAST ONE β-LACTAM ANTIBIOTIC AGENT
US6210710B1 (en) * 1997-04-28 2001-04-03 Hercules Incorporated Sustained release polymer blend for pharmaceutical applications
EP0987020A1 (en) * 1998-09-04 2000-03-22 Pharma Pass LLC Metoprolol composition and processes for manufacturing the same
EP0974343B1 (en) * 1998-07-22 2004-09-29 Pharma Pass II LLC Process for manufacturing a solid metoprolol composition
SE0003125D0 (en) * 2000-09-05 2000-09-05 Astrazeneca Ab Modified polymers

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1327938A (en) * 1969-12-17 1973-08-22 Sucrest Corp Composition for use in forming tablets
DE2130545A1 (en) * 1971-06-19 1972-12-21 Merck Patent Gmbh Pharmaceutical molded body
CH630257A5 (en) * 1975-03-17 1982-06-15 Hoffmann La Roche Sustained release formulation
DK130287D0 (en) * 1987-03-13 1987-03-13 Benzon As Alfred ORAL PREPARATION
US5169639A (en) * 1988-09-19 1992-12-08 Edward Mendell Co., Inc. Controlled release verapamil tablets
JP2628231B2 (en) * 1992-12-30 1997-07-09 エフ エム シー コーポレーション Konjac glucomannan readily available as a release-controlling excipient

Also Published As

Publication number Publication date
MX9704043A (en) 1998-02-28
EP0793485A1 (en) 1997-09-10
EP0793485A4 (en) 1998-08-26
AU709413B2 (en) 1999-08-26
CA2205351A1 (en) 1996-06-06
CN1172429A (en) 1998-02-04
WO1996016638A1 (en) 1996-06-06
JPH10509981A (en) 1998-09-29
NO972486D0 (en) 1997-05-30
NO972486L (en) 1997-07-31
FI972304A0 (en) 1997-05-30
FI972304A (en) 1997-05-30

Similar Documents

Publication Publication Date Title
AU5676596A (en) Oral insulin delivery
AU5414194A (en) Drug delivery systems, characterised by a photolabile linkage
EP0897708A3 (en) Drug delivery container having a luer filter
AU6957596A (en) Implantable drug delivery apparatus
AU4505496A (en) Sustained-release drug delivery system
AU1850897A (en) Powdered medication inhaler
AU2827095A (en) Controlled release oral drug delivery system
AU4225196A (en) Transdermal drug delivery device containing a dessicant
IL124804A0 (en) Drug delivery device
EP0828564A4 (en) Electrostatically depositing a medicament powder
AU7676894A (en) Convection-enhanced drug delivery
AU5266698A (en) Directional drug delivery stent
AU5576296A (en) Shuttle stent delivery catheter
AU2490599A (en) Implantable drug infusion device having a flow regulator
AU3342399A (en) A delivery catheter
NZ307318A (en) A substituted polyanionic cyclodextrin compound and medicaments
IL116743A0 (en) Pharmaceutical composition comprising a growth hormone
AU7617296A (en) Device for preparing a medicinal solution reconstituted from two components
AU5408198A (en) A device for dispensing artificial teeth
AU4372096A (en) Sustained-release drug delivery employing a powdered hydrocolloid gum obtainable from higher plants
AU5401796A (en) Solid delivery form for oral use
AU2080695A (en) Pharmaceutical inhalation compositions containing a solid active ingredient
AU4595196A (en) Nsaid delivery employing a powdered hydrocolloid gum obtainable from higher plants
AU698450B2 (en) Seed delivery device for seed planter
IL114371A0 (en) A dose setting syringe

Legal Events

Date Code Title Description
PC Assignment registered

Owner name: VENTURE LENDING

Free format text: FORMER OWNER WAS: CIBUS PHARMACEUTICAL, INC.

PC Assignment registered

Owner name: AMARIN DEVELOPMENT COMPANY

Free format text: FORMER OWNER WAS: VENTURE LENDING

TH Corrigenda

Free format text: IN VOL 15, NO 32, PAGE(S) 6967 UNDER THE HEADING ASSIGNMENTS REGISTERED THE NAME OF THE APPLICANT IN REGARD TO PATENT NUMBER 709413 SHOULD READ: AMARIN DEVELOPMENT AB